{"news_desk": "Business", "print_page": "1", "subsection_name": null, "section_name": "Business Day", "byline": {"original": "By ANDREW POLLACK", "person": [{"firstname": "Andrew", "rank": 1, "lastname": "POLLACK", "organization": "", "role": "reported"}]}, "abstract": "Bristol-Myers Squibb says its best-selling immunotherapy drug Opdivo failed as initial treatment for lung cancer in clinical trial; announcement plunges manufacturer's shares 16 percent and raises value of shares of rival Merck, makers of Keytruda, immunotherapy medication that succeeded in similar clinical trial.", "type_of_material": "News", "word_count": "1045", "keywords": [{"rank": "1", "value": "Clinical Trials", "is_major": "N", "name": "subject"}, {"rank": "2", "value": "Lung Cancer", "is_major": "Y", "name": "subject"}, {"rank": "3", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "name": "subject"}, {"rank": "4", "value": "Bristol Myers Squibb Company", "is_major": "Y", "name": "organizations"}, {"rank": "5", "value": "Merck & Company Inc", "is_major": "Y", "name": "organizations"}], "lead_paragraph": "Bristol-Myers Squibb said the drug had not slowed the progression of advanced lung cancer in a test seeking approval to use it as an initial treatment.", "pub_date": "2016-08-05T15:59:16+0000", "document_type": "article", "source": "The New York Times", "snippet": "Bristol-Myers Squibb said the drug had not slowed the progression of advanced lung cancer in a test seeking approval to use it as an initial treatment....", "multimedia": [{"height": 126, "subtype": "wide", "legacy": {"widewidth": "190", "wide": "images/2016/08/06/business/06DRUG/06DRUG-thumbWide.jpg", "wideheight": "126"}, "type": "image", "width": 190, "url": "images/2016/08/06/business/06DRUG/06DRUG-thumbWide.jpg"}, {"height": 401, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "401", "xlarge": "images/2016/08/06/business/06DRUG/06DRUG-articleLarge.jpg"}, "type": "image", "width": 600, "url": "images/2016/08/06/business/06DRUG/06DRUG-articleLarge.jpg"}, {"height": 75, "subtype": "thumbnail", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/08/06/business/06DRUG/06DRUG-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "url": "images/2016/08/06/business/06DRUG/06DRUG-thumbStandard.jpg"}], "web_url": "http://www.nytimes.com/2016/08/06/business/lung-cancer-drug-opdivo-fails-clinical-trial-to-expand-use.html", "slideshow_credits": null, "blog": [], "_id": "57aa084f95d0e021d797ee8d", "headline": {"main": "Immunotherapy Drug Opdivo Fails Clinical Trial to Expand Use", "print_headline": "Immunotherapy Drug Fails Lung Cancer Trial"}}